A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

Recruiting

Early Phase 1

KB111A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

Sponsor:

Krystal Biotech, Inc.

Code:

NCT07717346

Conditions

Hailey Hailey Disease

Skin Diseases

Lesion Skin

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

KB111

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-08. This information was provided to ClinicalTrials.gov by Krystal Biotech, Inc. on 2026-07-21.